Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11347-11355
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11347
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11347
Figure 4 miR-218 increased chemosensitivity to cisplatin could be accelerated by overexpression of mTOR.
Cells were transfected with miR-NC, or miR-218 with or without mTOR cDNA. Cells were exposed to cisplatin for further detection 10 h after transfection. A: Tumor cells proliferation assay of different cisplatin concentrations. 6 × 103 cells were seeded in 96-well plates and incubated with different concentration of cisplatin for 72 h. Data are presented as mean ± SD from three independent experiments performed in sextuple; B: Cell proliferation in the presence of 12 μmol/L cisplatin. Data are presented as mean ± SD from three independent experiments performed in sextuple. aP < 0.05 vs control; cP < 0.05 vs miR-218 + mTOR.
- Citation: Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB, Fang ZY, Cui SZ, Wang LT. MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin. World J Gastroenterol 2014; 20(32): 11347-11355
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11347.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11347